Caris Life Sciences (CAI) Exchange Rate Effect (2024 - 2026)
Caris Life Sciences' (CAI) quarterly Exchange Rate Effect came in at -$10000.0 in Q1 2026, down 350.0% year-on-year from $4000.0 in Q1 2025, and up 65.52% quarter-over-quarter from -$29000.0 in Q4 2025.
Caris Life Sciences (CAI) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Caris Life Sciences' Exchange Rate Effect history runs 3 years deep, the most recent figure standing at -$10000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 350.0% year-over-year to -$10000.0 in Q1 2026; TTM through Mar 2026 was $116000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $130000.0, up 3350.0% from the prior year.
- Exchange Rate Effect improved to -$10000.0 in Q1 2026 per CAI's latest filing, from -$29000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $93000.0 in Q2 2025 and bottomed at -$29000.0 in Q4 2025.
- The 3-year median for Exchange Rate Effect is -$1000.0 (2024), against an average of $14714.3.
- Biggest YoY gain for Exchange Rate Effect was 487.5% in 2025; the steepest drop was 2800.0% in 2025.
- Year by year, Exchange Rate Effect stood at -$1000.0 in 2024, then plunged by 2800.0% to -$29000.0 in 2025, then surged by 65.52% to -$10000.0 in 2026.
- Per Business Quant, the three latest CAI Exchange Rate Effect figures stand at -$10000.0 (Q1 2026), -$29000.0 (Q4 2025), and $62000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Caris Life Sciences | 4.42 Bn | 3.60 Bn | 214.23 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | -16,000.00 |
| Sep 30, 2024 | -16,000.00 |